COVID-19 vaccines and their potential use in patients with hematological malignancies

Many uncertainties exist regarding COVID-19 vaccination in patients undergoing treatment for hematological malignancies. We intend the illustrate the various types of COVID-19 vaccine currently in use and their mechanism of action. We have complied, recommendations for COVID-19 vaccination in patients suffering with specific hematological malignancies and those undergoing HCT and CAR-T cell therapy in this review. We have also discussed the available safety data for COVID-19 vaccination in the immunocompromised population.